First People's Hospital Of Hangzhou
Clinical trials sponsored by First People's Hospital Of Hangzhou, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo aims to simplify stomach infection treatment Results expected Oct 2026 (estimated)
- Scientists dive deep into rare lung Cancer's DNA and immune defenses Results expected Aug 2027 (estimated)
-
Can a smaller calcium dose do the same job in pregnancy?
Disease control CompletedThis trial asks whether a lower daily calcium dose (300 mg) can match the standard higher dose (600 mg) in supporting bone health during pregnancy. Pregnant women between 22 and 28 weeks of gestation will be randomly assigned to one of the two doses. Researchers will measure chan…
Phase 4 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New study pits spyglass against shock waves for tough pancreatic stones
Disease control CompletedThis study compared two methods for removing large pancreatic duct stones that couldn't be cleared with standard endoscopy. One method uses a tiny camera called SpyGlass to break up stones, while the other uses shock waves from outside the body (ESWL). The trial involved 116 pati…
Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC